{
  "trial_id": "NCT00818623",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, ECOG score, testosterone level, PSA value, life expectancy, history of severe asthma, history of anaphylactic reactions, history of Quincke's Oedema, hypersensitivity towards any component of FE200486, history of cancer disease within the last ten years, signs of liver impairment, other laboratory abnormalities, significant neurological disorder, significant gastrointestinal disorder, significant renal disorder, significant hepatic disorder, significant cardiovascular disorder, significant psychological disorder, significant pulmonary disorder, significant metabolic disorder, significant endocrine disorder, significant haematological disorder, significant dermatological disorder, significant infectious disorder, excessive alcohol abuse, drug abuse, mental capacity, language proficiency, previous investigational product use, previous trial participation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Serum prostate-specific antigen levels",
          "PSA value"
        ],
        [
          "Serum testosterone levels",
          "testosterone level"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Race/Ethnicity",
        "Curative intent",
        "Gleason score",
        "Stage of prostate cancer",
        "Body mass index",
        "Time since prostate cancer diagnosis",
        "Weight"
      ],
      "remaining_candidate_features": [
        "ECOG score",
        "life expectancy",
        "history of severe asthma",
        "history of anaphylactic reactions",
        "history of Quincke's Oedema",
        "hypersensitivity towards any component of FE200486",
        "history of cancer disease within the last ten years",
        "signs of liver impairment",
        "other laboratory abnormalities",
        "significant neurological disorder",
        "significant gastrointestinal disorder",
        "significant renal disorder",
        "significant hepatic disorder",
        "significant cardiovascular disorder",
        "significant psychological disorder",
        "significant pulmonary disorder",
        "significant metabolic disorder",
        "significant endocrine disorder",
        "significant haematological disorder",
        "significant dermatological disorder",
        "significant infectious disorder",
        "excessive alcohol abuse",
        "drug abuse",
        "mental capacity",
        "language proficiency",
        "previous investigational product use",
        "previous trial participation"
      ]
    },
    "processed-gen-response": "Age, ECOG score, testosterone level, PSA value, life expectancy, history of severe asthma, history of anaphylactic reactions, history of Quincke's Oedema, hypersensitivity towards any component of FE200486, history of cancer disease within the last ten years, signs of liver impairment, other laboratory abnormalities, significant neurological disorder, significant gastrointestinal disorder, significant renal disorder, significant hepatic disorder, significant cardiovascular disorder, significant psychological disorder, significant pulmonary disorder, significant metabolic disorder, significant endocrine disorder, significant haematological disorder, significant dermatological disorder, significant infectious disorder, excessive alcohol abuse, drug abuse, mental capacity, language proficiency, previous investigational product use, previous trial participation."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG score, Baseline testosterone level, PSA value, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Serum prostate-specific antigen levels",
          "PSA value"
        ],
        [
          "Serum testosterone levels",
          "Baseline testosterone level"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Curative intent",
        "Gleason score",
        "Stage of prostate cancer",
        "Body mass index",
        "Time since prostate cancer diagnosis",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "ECOG score",
        "Life expectancy"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Race/Ethnicity, Region of Enrollment, ECOG score, Baseline testosterone level, PSA value, Life expectancy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Male, ECOG score, Testosterone level, PSA value, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Male"
        ],
        [
          "Serum prostate-specific antigen levels",
          "PSA value"
        ],
        [
          "Serum testosterone levels",
          "Testosterone level"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race/Ethnicity",
        "Curative intent",
        "Gleason score",
        "Stage of prostate cancer",
        "Body mass index",
        "Time since prostate cancer diagnosis",
        "Weight"
      ],
      "remaining_candidate_features": [
        "ECOG score",
        "Life expectancy"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, ECOG score, Testosterone level, PSA value, Life expectancy"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, ECOG score, Testosterone level, PSA value, Life expectancy, Medical history (prostate cancer, hormonal treatment, asthma, anaphylactic reactions, Quincke's Oedema, cancer disease, liver impairment, neurological disorders, gastrointestinal disorders, renal disorders, hepatic disorders, cardiovascular disorders, psychological disorders, pulmonary disorders, metabolic disorders, endocrine disorders, haematological disorders, dermatological disorders, infectious disorders), Medication use (hormonal treatment, investigational products), Alcohol use, Drug abuse.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Serum prostate-specific antigen levels",
          "PSA value"
        ],
        [
          "Serum testosterone levels",
          "Testosterone level"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Race/Ethnicity",
        "Curative intent",
        "Gleason score",
        "Stage of prostate cancer",
        "Body mass index",
        "Time since prostate cancer diagnosis",
        "Weight"
      ],
      "remaining_candidate_features": [
        "ECOG score",
        "Life expectancy",
        "Medical history (prostate cancer, hormonal treatment, asthma, anaphylactic reactions, Quincke's Oedema, cancer disease, liver impairment, neurological disorders, gastrointestinal disorders, renal disorders, hepatic disorders, cardiovascular disorders, psychological disorders, pulmonary disorders, metabolic disorders, endocrine disorders, haematological disorders, dermatological disorders, infectious disorders)",
        "Medication use (hormonal treatment, investigational products)",
        "Alcohol use",
        "Drug abuse"
      ]
    },
    "processed-gen-response": "Age, ECOG score, Testosterone level, PSA value, Life expectancy, Medical history (prostate cancer, hormonal treatment, asthma, anaphylactic reactions, Quincke's Oedema, cancer disease, liver impairment, neurological disorders, gastrointestinal disorders, renal disorders, hepatic disorders, cardiovascular disorders, psychological disorders, pulmonary disorders, metabolic disorders, endocrine disorders, haematological disorders, dermatological disorders, infectious disorders), Medication use (hormonal treatment, investigational products), Alcohol use, Drug abuse."
  }
}